Argus Research has reiterated a ‘Buy’ recommendation for Novo Nordisk (NVO), setting a target price of $140, which indicates a potential upside from its current trading price of $107.
Argus Research has suggested BUY Call for Comcast Corporation (NASDAQ: CMCSA) with a target price of $50, reflecting confidence in the company’s strategic initiatives and growth potential.
Argus Research has issued a “Buy” rating on DraftKings Incorporated (NASDAQ: DKNG), increasing its price target from $40 to $50 as the company navigates through the expanding online sports betting
Argus Research has reiterated its Buy rating for Lyft Inc. (NASDAQ: LYFT), raising the target price to $23, citing growth in active riders, rides, and gross bookings.